The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3)

Abstract Background Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects in the early stage of atherosclerosis in patients with type 2 diabetes, although similar effects in advanced atherosclerosis were not shown in recent randomized placebo-controlled studies. Therefore, we investi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura, Tatsuya Atsumi, SAIS Study Group
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-10-01
coleção:	Cardiovascular Diabetology
Assuntos:	Type 2 diabetes Dipeptidyl peptidase-4 inhibitor Vildagliptin Vascular endothelial function
Acesso em linha:	http://link.springer.com/article/10.1186/s12933-017-0607-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!